Details for New Drug Application (NDA): 084342
✉ Email this page to a colleague
NDA 084342 describes DEXACEN-4, which is a drug marketed by Cent Pharms and is included in one NDA. Additional details are available on the DEXACEN-4 profile page.
The generic ingredient in DEXACEN-4 is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.
The generic ingredient in DEXACEN-4 is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.
Summary for 084342
| Tradename: | DEXACEN-4 |
| Applicant: | Cent Pharms |
| Ingredient: | dexamethasone sodium phosphate |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 4MG PHOSPHATE/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
